Draft concept paper on viral safety of plasma-derived medicinal products with respect to hepatitis E virus

  • Email
  • Help

Document details

Download document Draft concept paper on viral safety of plasma-derived medicinal products with respect to hepatitis E virus
Reference number EMA/CHMP/BWP/78086/2014
Status draft: consultation open
First published 02/05/2014
Last updated 02/05/2014
Consultation start date 02/05/2014
Consultation end date 31/07/2014
Email address for submissions bpwpsecretariat@ema.europa.eu

Summary

Viral safety of plasma-derived medicinal products needs to be kept under review as viruses are identified that can be present in the plasma starting material. Initiating action with a workshop will provide an effective means of bringing together and discussing the currently available information on this topic. This will then allow further actions to be identified.